8-K
XBRL
8-K
- Company
- ELITE PHARMACEUTICALS INC /NV/
- Filed
- June 16, 2025
- Period of Report
- June 16, 2025
- Accession Number
- 0001641172-25-015172
An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →